Recall of Amlodipine Medication: Important Information for High Blood Pressure and Angina Patients

2023-10-27 13:04:21

Following a packaging error, the Medicines Agency announces the recall of a medication prescribed for high blood pressure and angina attacks.

You take a blood pressure medication ? Or to prevent the risk of angina? The Medicines Agency (ANSM) announced on Friday October 27 the recall of boxes of Amlodipine produced by the EG Labo laboratory because of a error occurred during packaging. “Of the plaquettes d’Amlodipine EG 5 mg have been packaged in boxes of Amlodipine EG 10 mg” explains the authority. Pharmacists must contact patients to whom they dispensed Amlodipine so that they can check and replace the medicine if it is one of the recalled batches. Likewise“THE patients affected by the inversion must return their box” in pharmacy.

The batches affected by the recall are:

► Amlodipine EG 5 mg, capsule – box of 30

Lot A53014 (expiration 02/2028)

► Amlodipine EG 10 mg, capsule – box of 30

Lot A53014 (expiration 02/2028)

The batch number is on the medicine box. If a reference other than A53014 is written on the box, you are not affected by the recall. The prizes were distributed from June 21, 2023.

What risk?

Amlodipine is used in the treatment of high blood pressure and the preventive treatment of angina attacks, particularly in cases ofAngor de Prinzmetal (coronary artery spasm). The risk for patients holding the recalled boxes is to take a underdosed medication SO less efficient. For the moment “no case of pharmacovigilance linked to the quality defect has not been reported to the laboratory to date. reassures the health agency in its communiqué. But by precautions, “if you feel suggestive symptoms of hypertension, such as headache, shortness of breath, dizziness, We invite you to consult your doctor“ advises the ANSM. On the other hand, do not stop or do not change your treatment without medical advice.